Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | ESR1 | P03372 | 5/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.46 |
| ▸ | RORC | P51449 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | PGR | P06401 | 2/20 | 0.38 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.38 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | TYR | P14679 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.38 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22267492 | 0.85 | ESR2 (0.44) | TSHRESR1ESR2CYP3A4RECQL | |
| SCHEMBL28622220 | 0.83 | TSHR (0.52) | TSHRESR1ESR2RORCCYP3A4 | |
| SCHEMBL30763515 | 0.83 | TSHR (0.52) | TSHRESR1ESR2RORCCYP3A4 | |
| SCHEMBL18203521 | 0.82 | ESR2 (0.45) | TSHRESR1ESR2CYP3A4RECQL | |
| SCHEMBL18704829 | 0.82 | ESR1 (0.42) | TSHRESR1ESR2CYP3A4RECQL | |
| SCHEMBL1104213 | 0.82 | TSHR (0.61) | TSHRRORCALOX15USP2ALDH1A1 | |
| SCHEMBL4639575 | 0.82 | ESR2 (0.47) | TSHRESR1ESR2CYP3A4RECQL | |
| SCHEMBL29492442 | 0.82 | TSHR (0.61) | TSHRRORCALOX15USP2ALDH1A1 | |
| SCHEMBL8777756 | 0.81 | ESR2 (0.44) | TSHRESR1ESR2CYP3A4RECQL | |
| SCHEMBL5273781 | 0.81 | ESR1 (0.59) | TSHRESR1ESR2CYP3A4PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3359596-B1 | PHOSPHATE ESTER COMPOSITION AND USE | SASOL USA CORP (US) | 2025-05-07 | — | — | EP | claimed |
| CN-108291053-B | Phosphate ester composition and use | 萨索尔（美国）公司 | 2020-10-16 | — | — | CN | claimed |
| US-10544173-B2 | Phosphate ester composition and use | SASOL (USA) CORPORATION (US) | 2020-01-28 | — | — | US | claimed |
| US-20180273556-A1 | Phosphate Ester Composition and Use | SASOL USA CORP (US) | 2018-09-27 | — | — | US | claimed |
| CN-108291053-A | Phosphate-ester composition and purposes | 萨索尔（美国）公司 | 2018-07-17 | — | — | CN | claimed |
| WO-2017062557-A1 | PHOSPHATE ESTER COMPOSITION AND USE | SASOL (USA) CORPORATION (US) | 2017-04-13 | — | — | WO | claimed |
| EP-3359596-B1 | PHOSPHATE ESTER COMPOSITION AND USE | SASOL USA CORP (US) | 2025-05-07 | — | — | EP | disclosed |
| US-11780946-B2 | Alternating copolymer, method of producing alternating copolymer, method of producing polymeric compound, and method of forming resist pattern | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-10-10 | — | — | US | disclosed |
| CN-108291053-B | Phosphate ester composition and use | 萨索尔（美国）公司 | 2020-10-16 | — | — | CN | disclosed |
| US-10544173-B2 | Phosphate ester composition and use | SASOL (USA) CORPORATION (US) | 2020-01-28 | — | — | US | disclosed |
| US-20180273556-A1 | Phosphate Ester Composition and Use | SASOL USA CORP (US) | 2018-09-27 | — | — | US | disclosed |
| CN-108291053-A | Phosphate-ester composition and purposes | 萨索尔（美国）公司 | 2018-07-17 | — | — | CN | disclosed |
| US-10011676-B2 | Compound containing phenolic hydroxyl group, phenolic resin, curable composition, cured product thereof, semiconductor sealing material, and printed circuit board | DIC CORPORATION (JP) | 2018-07-03 | — | — | US | disclosed |
| US-8232039-B2 | Polymer and resist composition comprising the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-07-31 | — | — | US | disclosed |
| US-8173352-B2 | Resist composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-05-08 | — | — | US | disclosed |
| US-20100151380-A1 | RESIST COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-17 | — | — | US | disclosed |
| US-20100136481-A1 | RESIST COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-03 | — | — | US | disclosed |
| US-20100124719-A1 | Polymer and Resist Composition Comprising the Same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-05-20 | — | — | US | disclosed |
| US-20100081085-A1 | Polymer and Resist Composition Comprising the Same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-04-01 | — | — | US | disclosed |
| US-4046818-A | SULFONATION | KOPPERS COMPANY, INC. (US) | 1977-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180273556-A1 | Phosphate Ester Composition and Use | PFKFB2, F12, PFKFB1 | TSHR 2652/4885ESR1 205/4885ESR2 196/4885 |
| US-10011676-B2 | Compound containing phenolic hydroxyl group, phenolic resin, curable composition, cured product thereof, semiconductor sealing material, and printed circuit board | ASH2L, SEM1, KDM1A | TSHR 4259/4885ESR1 500/4885ESR2 990/4885 |
| US-10544173-B2 | Phosphate ester composition and use | PFKFB2, F12, PFKFB1 | TSHR 2652/4885ESR1 205/4885ESR2 196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.